Daniel Donovan - Jun 15, 2022 Form 3 Insider Report for Panbela Therapeutics, Inc. (PBLA)

Role
Director
Signature
/s/ Joshua L. Colburn, Attorney-in-Fact
Stock symbol
PBLA
Transactions as of
Jun 15, 2022
Transactions value $
$0
Form type
3
Date filed
6/24/2022, 04:46 PM
Next filing
Mar 29, 2023

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
holding PBLA Common Stock 71.5K Jun 15, 2022 Direct
holding PBLA Common Stock 163K Jun 15, 2022 By GDB Investments, LLP F1
holding PBLA Common Stock 75.5K Jun 15, 2022 By Westport Boys, LLC F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
holding PBLA Stock Option (right to buy) Jun 15, 2022 Common Stock 37.3K $0.22 Direct F2
holding PBLA Stock Option (right to buy) Jun 15, 2022 Common Stock 22.2K $0.22 Direct F2
holding PBLA Warrants (right to buy) Jun 15, 2022 Common Stock 5.18K $6.76 By GDB Investments, LLP F1, F2
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reporting person disclaims beneficial ownership of these securities except to the extent of his pecuniary interest therein.
F2 Fully vested.

Remarks:

Exhibit List: Power of Attorney EX-24